Mean arterial blood pressure measured by invasive transducer attached to arterial catheter
Ketamine Versus Fentanyl for Induction of Anesthesia in Septic Shock
Brief Summary
Intervention / Treatment
-
Ketamine (DRUG)Patients will receive :1 mg/Kg ketamine for induction of anesthesia
-
Fentanyl (DRUG)Patients will receive :2.5 mcg/Kg fentanyl for induction of anesthesia
-
Midazolam (DRUG)Patients will receive 0.05 mg/Kg midazolam
Condition or Disease
- Septic Shock
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Completed |
Study results: | No Results Available |
Age: | 18 Years to 65 Years |
Enrollment: | 42 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Treatment |
MaskingQUADRUPLE:
|
Clinical Trial Dates
Start date: | Jan 25, 2018 | ACTUAL |
---|---|---|
Primary Completion: | Dec 25, 2019 | ACTUAL |
Completion Date: | Dec 30, 2019 | ACTUAL |
Study First Posted: | Aug 16, 2017 | ACTUAL |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Jan 25, 2020 |
Sponsors / Collaborators
Location
Ketamine has been reported as an induction anesthetic with a sympathomimetic activity. In patients with intact autonomic nervous system ketamine increases heart rate, cardiac output, and arterial blood pressure (ABP). Despite its sympathomimetic activity in hemodynamically stable patients, the hemodynamic response to ketamine in unstable cardiovascular conditions is not clear. No studies to the best of our knowledge compared Ketamine-based and opioid-based protocols in rapid sequence induction of anesthesia in hemodynamically unstable patients.
In this study, patients with severe sepsis or septic shock scheduled for surgery will be assigned to receive either ketamine or fentanyl for induction of anesthesia. After induction of anesthesia, endotracheal tube will be inserted aided by succinyl choline. Invasive blood pressure will be monitored through a transducer connected to arterial catheter. Electrical velocimetry (cardiometry) device will be used for non-invasive monitoring of cardiac output and stroke volume.
Participant Groups
-
This group of patients will receive: 1 mg/Kg ketamine + 0.05 mg/Kg midazolam for induction of anesthesia. Endotracheal tube will be inserted aided by 1 mg/Kg succinyl choline. Patients will undergo surgical procedure to eliminate the source of sepsis e.g. abdominal exploration. Invasive blood pressure monitor will be connected to the patient through an arterial catheter. Electrical velocimetry (cardiometry) device will be connected to the patient to measure cardiac output, stroke volume, and systemic vascular resistance.
-
2.5 mg/Kg fentanyl + 0.05 mg/Kg midazolam for induction of anesthesia. Endotracheal tube will be inserted aided by 1 mg/Kg succinyl choline. Patients will undergo surgical procedure to eliminate the source of sepsis e.g. abdominal exploration. Invasive blood pressure monitor will be connected to the patient through an arterial catheter. Electrical velocimetry (cardiometry) device will be connected to the patient to measure cardiac output, stroke volume, and systemic vascular resistance.
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 18 |
Maximum Age: | 65 |
Age Groups: | Adult / Older Adult |
Healthy Volunteers: | Yes |
* Sepsis patients
* With shock index (heart rate divided by systolic blood pressure) \>0.7. or Sepsis patients with norepinephrine infusion.
Exclusion Criteria:
* Traumatic brain injury
* Cerebrovascular disorders
Primary Outcomes
Secondary Outcomes
-
cardiac output measured in litres per minute measured by electrical velocimetry
-
cardiac stroke volume in milliliters measured by electrical velocimetry
-
heart rate measured in beat per minute
-
serum lactate measured in mmol/liter
-
total dose of norepinephrine measured in micrograms
-
the concentration of inhalational anesthetic (%)
-
The percent of patients with severe hypotension after induction of anesthesia requiring stoppage of inhalational anesthesia or increasing the dose of vasopressors
More Details
NCT Number: | NCT03251170 |
---|---|
Other IDs: | N-12-2018 |
Study URL: | https://clinicaltrials.gov/study/NCT03251170 |